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Background: There is evidence of under-detection and poor management of pain in patients with dementia,
in both long-term and acute care. Accurate assessment of pain in people with dementia is challenging and pain
assessment tools have received considerable attention over the years, with an increasing number of tools made
available. Systematic reviews on the evidence of their validity and utility mostly compare different sets of tools.
This review of systematic reviews analyses and summarises evidence concerning the psychometric properties and
clinical utility of pain assessment tools in adults with dementia or cognitive impairment.
Methods: We searched for systematic reviews of pain assessment tools providing evidence of reliability, validity
and clinical utility. Two reviewers independently assessed each review and extracted data from them, with a third
reviewer mediating when consensus was not reached. Analysis of the data was carried out collaboratively. The
reviews were synthesised using a narrative synthesis approach.
Results: We retrieved 441 potentially eligible reviews, 23 met the criteria for inclusion and 8 provided data for
extraction. Each review evaluated between 8 and 13 tools, in aggregate providing evidence on a total of 28 tools.
The quality of the reviews varied and the reporting often lacked sufficient methodological detail for quality
assessment. The 28 tools appear to have been studied in a variety of settings and with varied types of patients.
The reviews identified several methodological limitations across the original studies. The lack of a ‘gold standard’
significantly hinders the evaluation of tools’ validity. Most importantly, the samples were small providing limited
evidence for use of any of the tools across settings or populations.
Conclusions: There are a considerable number of pain assessment tools available for use with the elderly cognitive
impaired population. However there is limited evidence about their reliability, validity and clinical utility. On the
basis of this review no one tool can be recommended given the existing evidence.
Keywords: Pain assessment, Pain scales, Aged, Dementia, Meta-reviewBackground
Dementia affects an estimated 44.4 million people
worldwide – a figure which is set to rise – and represents
an important public health issue, costing an estimated US
$604 billion each year [1]. Dementia presents a particular
challenge for treatment and care due to the progressive
cognitive and functional decline that are hallmarks of the
condition. In particular, loss of language and the ability to* Correspondence: v.lichtner@leeds.ac.uk
1School of Healthcare, University of Leeds, Leeds, UK
Full list of author information is available at the end of the article
© 2014 Lichtner et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.communicate raises the risk of unmet need. A critical
example of this issue is in the assessment of pain.
Pain is common in older adults, with up to one third of
community-dwelling people over 60 experiencing regular
pain and 50% of people over 80 regularly taking analgesics
[2]. Although pain in dementia is difficult to assess, the
literature agrees that at least 50% of people with dementia
also regularly experience pain [3], which is predominantly,
but not exclusively related to the musculoskeletal system.
Osteoarthritis is very common in these individuals [4], andl. This is an Open Access article distributed under the terms of the Creative
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infections and underlying neuropathy due to comor-
bidities [5].
In addition to significant distress and discomfort,
untreated pain can also be a causative factor in key symp-
toms and quality of life indicators for people with demen-
tia. Behavioural and psychological symptoms of dementia
such as agitation and aggression often arise as a result of
underlying pain, presenting a considerable challenge for
treatment and care that may lead to institutionalisation or
prescriptions of antipsychotic medications that carry ser-
ious safety concerns [6]. The accurate and timely assess-
ment of pain is therefore of critical importance when
considering the overall care for people with dementia. In
general, due to the subjectivity of pain, self-report is con-
sidered to be the gold standard for pain assessment. While
people with mild to moderate dementia are often able to
report their pain verbally or use simple visual or numerical
pain intensity assessment tools, these options are not feas-
ible for use with people with later stage dementia in whom
communication ability is severely impaired [7,8]. As a
result previous work has shown that pain is frequently
under-detected and poorly managed in people with de-
mentia, in both long-term and acute care [9-12].
In the absence of accurate self-report it has been ne-
cessary to develop observational tools to be used in both
research and practice, based on the interpretation of be-
havioural cues as a proxy for the presence of pain. This
approach has resulted in a proliferation in the number
of pain assessment instruments developed to identify be-
havioural indicators of pain in people with dementia and
other cognitive impairment. The most structured of these
are predominantly based on guidance published by the
American Geriatrics Society [13], which presents six do-
mains for pain assessment in older adults. These include
facial expression, negative vocalisation, body language,
changes in activity patterns, changes in interpersonal inter-
actions and mental status changes. However, the in-
terpretation of many of these behaviours is complex
when applied to dementia due to considerable overlap
with other common behavioural symptoms or cognitive
deficits which may confound an assessment, manifesting
from boredom, hunger, anxiety, depression or disorienta-
tion [14]. This increases the complexity of identifying the
presence of pain accurately in patients with dementia and
raises questions about the validity of existing instruments.
The psychometric and discriminative properties and the
clinical utility of currently available instruments are as yet
unclear. As a result there is no clear guidance for clini-
cians and care staff on the effective assessment of pain,
nor how this should inform treatment and care decision-
making. A large number of systematic reviews have
been published which analyse the relative value and
strength of evidence of existing pain tools. There is a needfor guidance on the best evidence available and for an
overall comprehensive synthesis.
This meta-review forms part of a larger programme of
research focusing on developing decision support inter-
ventions to assist with the assessment and management of
pain in patients with dementia in an acute care setting. A
key aspect of this work is to identify existing assessment
tools with validation data pertaining to the treatment of
people with dementia. This meta-review presents a thor-
ough synthesis of current systematic review literature con-
cerning the psychometric properties and clinical utility of
pain assessment tools for the assessment of pain in adults
with dementia. It provides a detailed picture of the state of
the field in the complex task of assessing pain.
Methods
For ease of reference, in this paper we refer to our system-
atic review of systematic reviews as a meta-review; we call
the systematic reviews considered for inclusion in the
meta-review reviews and refer to publications included in
the reviews as studies; we use the term records to refer to
the bibliographic data of publications of reviews (for the
most part retrieved thought online database searches); the
terms (pain assessment) scales, tools and instruments are
used interchangeably. The process of the meta-review
followed guidance from The Cochrane Collaboration [15]
and the Joanna Briggs Institute [16]. In undertaking this
meta-review, our review questions were the following:
1) Which tools are available to assess pain in adults
with dementia?
2) In which settings are they used and with what
patient populations?
3) What are their reliability, validity and clinical utility?
Criteria for considering reviews for inclusion
Definitions of criteria for inclusion of reviews in the meta-
review followed an adapted SPICE structure (Setting,
Population, Intervention, Comparison, method of Evaluation)
[16] (Table 1). We included systematic reviews of pain
assessment tools involving adults with dementia or with
cognitive impairment. Dementia and cognitive impairment
were defined according to the US National Library of
Medicine Medical Subject Heading (MeSH) vocabulary.
Dementia was defined as “an acquired organic mental
disorder with loss of intellectual abilities of sufficient
severity to interfere with social or occupational function-
ing […]” [17]. The Dementia MeSH term covers more
specific subheadings such as Alzheimer Disease or
Vascular Dementia. Cognition Disorder was defined as:
“Disturbances in the mental process related to thinking,
reasoning, and judgment” [18] (distinct from, not including,
Delirium). We did not include Learning Disorders, defined
as: “Conditions characterized by a significant discrepancy
Table 1 Inclusion and exclusion criteria
Criteria Definitions
Setting Reviews pertaining to any setting Settings are for example acute hospitals, nursing homes, community settings.
Patient
population
Reviews of studies limited to adult dementia
patients or adults with cognitive impairment.
Dementia defined as “an acquired organic mental disorder with loss of intellectual
abilities of sufficient severity to interfere with social or occupational functioning.
The dysfunction is multifaceted […]”
All stages of dementia in adults
considered (e.g. mild, severe).
Cognitive impairment defined as Cognition Disorder: “Disturbances in the mental
process related to thinking, reasoning, and judgment”. Does not include Learning
Disorders. (Source: MeSH vocabulary -http://www.nlm.nih.gov/mesh/)
Intervention Reviews of studies of the assessment of pain and
of pain assessment tools. Reviews that include
management of pain considered if they also
cover assessment of pain.
Pain assessment as defined by IASP “entails a comprehensive evaluation of the
patient’s pain, symptoms, functional status, and clinical history […]”.
All forms of pain considered (e,g. acute pain,
persistent), without distinction on location
of pain (e.g. abdominal pain).
“[…] The assessment process is essentially a dialogue between the patient and the
health care provider that addresses the nature, location and extent of the pain, and
looks at the patient’s daily life, and concludes with the pharmaceutical and
nonpharmaceutical treatment options available to manage it” [20]. Evaluation tools
may be used in this process: “To varying degrees, these tools attempt to locate and
quantify the severity and duration of the patient’s subjective pain experience […]” [20].
Reviews of studies of pain assessment included,
irrespective of the outcomes of the assessment
(e.g. patients being in pain or not).
Evaluation
(method of)
Systematic reviews only to be included Definition of systematic review:
1. Review carried out systematically – i.e. publication that makes explicit the
authors’ intention to review or summarise the literature (e.g. with review,
overview, or meta-analysis in the title or in a section heading) [21].
2. Satisfying the following criteria [22]:
- Clear set of objectives: explicit and clear research question
- Reproducible methodology: the paper clearly explains how the evidence was
retrieved, including sources and search strategy and the inclusion (and exclusion)
criteria
- Assessment of validity of the findings (e.g. assessment of risk of bias)
- Systematic presentation and synthesis of findings beyond those provided by
single studies.
Additional
criteria
Reviews to be included only if with data and/or
assessment of reliability and/or validity and/or
clinical utility
Reliability: “the degree to which the measurement is free from measurement
error” [23].
Validity: “the degree to which the [instrument] measures the construct(s) it
purports to measure” [23].
Inclusion limited to English language Clinical utility: “the usefulness of the measure for decision making”, i.e. to inform
further action, such as the administration of analgesics [24].
The definition of criteria for inclusion of potentially relevant reviews follows an adapted SPICE structure (Setting, Population, Intervention, Comparison, method of
Evaluation) [16]. All criteria must be met for reviews to be included.
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their ability to acquire new language and other cognitive
skills. […]” [19]. Examples of learning disorders of this
type are dyslexia, dyscalculia, and dysgraphia.
We included reviews regardless of setting (e.g. acute,
or nursing/care homes), type, location or intensity of
pain (e.g. acute pain, persistent), and outcomes of the pain
assessment (e.g. patients being in pain or not). Reviews
were included if they provided psychometric data for the
pain assessment tools and were available in English. We
excluded publications, such as narrative reviews or case
reports, which did not provide psychometric data or were
not categorized as systematic reviews [22] (see Table 1 for
our systematic review definition).Search methods for identification of reviews
The following databases were searched (details pro-
vided in Table 2): Medline, All EBM Reviews (including
Cochrane DSR, ACP Journal Club, DARE, CCTR, CMR,
HTA, and NHSEED), Embase, PsycINFO, and CINHAL; the
searches were carried out all on the same date (12 March
2013). Additional searches included the Joanna Briggs
Institute (JBI) Library (The JBI Database of Systematic
Reviews and Implementation Reports) and the Centre for
Reviews and Dissemination database. Further data was
retrieved through reference chaining. No grey literature
was sought.
The search strategy used a combination of text words
and established indexing terms such as Medical Subject
Table 2 Literature search: databases and details of numbers of records retrieved
Date/time Database # records retrieved
(including duplicates)
# records retrieved
(excluding duplicates)
12 March 2013 11:12 MEDLINE (specifically: Ovid MEDLINE 1946 to February
Week 4 2013)
209 208
12 March 2013 11:22 Ovid MEDLINE In-Process & Other Non-Indexed
Citations March 11, 2013
0 0
12 March 2013 11:14 All EBM Reviews - Cochrane DSR, ACP Journal Club,
DARE, CCTR, CMR, HTA, and NHSEED
68 67
12 March 2013 12:05 Embase (1996 to 2013 Week 10) 74 73
12 March 2013 12:22 PsycINFO (1806 to March Week 1 2013) 68 0
12 March 2013 13:40 CINHAL 78 0
12 March 2013 14:15 The Joanna Briggs Institute (JBI) Library - The JBI Database
of Systematic Reviews and Implementation Reports
6 0
12 March 2013 14:49 Centre for Reviews and Dissemination database 5 0
Total: 508 441 (67 duplicates – i.e. 11 records
retrieved in 2 or more databases)
A summary of the databases searched, the number of bibliographic records retrieved for each database, including and excluding duplicates. Duplicates consists of
records retrieved in two or more databases.
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relevant SPICE concepts. Search terms were identified
by comparing published search strategies adopted by re-
views in similar areas (such as [21,25]), or on the subject
of pain or pain management tools, not specifically for
the same patient population [26], using the search strat-
egy for retrieving reviews outlined by Montori et al. [27].
Detailed search strategies were optimised for each elec-
tronic database searched (see Additional file 1).
Selection of reviews
Four reviewers (DD, MB, VL, PE) screened all search re-
sults, initially on the basis of title and abstract and then
the full text of potentially eligible papers (Figure 1). The
results of the search were divided into two sets among
the reviewers, so that each review was assessed by two
people independently. When consensus could not be
reached, the reviews were referred to a third party (SJC)
(details of this process available in Additional files 2
and 3).
Assessment of methodological quality of included
reviews
The PRISMA guidance on systematic reviews explains
how, in carrying out a systematic review, it is important
“to distinguish between quality and risk of bias and to
focus on evaluating and reporting the latter” [22]. The au-
thors encourage the reviewers “to think ahead carefully
about what risks of bias (methodological and clinical) may
have a bearing on the results of their systematic reviews”
[22]. In our meta-review, the risk of bias may reside in
each review considered for inclusion, as well as in the ori-
ginal studies that comprise that review. We did not access
the studies to be able to accurately judge their quality orrisk of bias. In terms of each review, we assessed risk of
bias in terms of how the review was conducted and the
criteria applied for inclusion/exclusion. Critical appraisal
was carried out by two independent reviewers, using the
AMSTAR systematic review critical appraisal tool [28].
Critical appraisal and evaluation of potential bias was car-
ried out at the time of data extraction, after screening was
completed on the basis of the inclusion criteria.
Data extraction and management
Data were extracted by two reviewers independently using
a set of data extraction forms which was developed for the
meta-review: 1) the AMSTAR checklist [28], 2) two forms
for data about the reviews and 3) one form for data about
the tools (Additional file 4). The latter included a field for
data extraction on the user-centredness of the tools, in-
formed by Dixon and Long’s work on the development of
health status instruments [29]. The data extraction forms
were both paper-based and built into a MS Access data-
base. At the time of data extraction, the reviews eligible for
inclusion were screened further on the basis of availability
of psychometric data of tools. At this point, we found that
some of the reviews initially identified as being eligible for
inclusion in the meta-review did not provide psychometric
data of tools and were subsequently excluded (this is dis-
cussed in detail in the results section). Data about the char-
acteristics of the tool (e.g. tool design and instructions for
use) were extracted from the reviews; we did not search
for, nor retrieve, the original tools. The reviews were syn-
thesised using a narrative synthesis approach.
Results
The search retrieved 441 potentially eligible unique records.
After screening titles and abstracts, and further removing
Table 3 Search strategy
SPICE categories Search terms*
Patient population: adults with
dementia or cognitive impairment
1. Dementia.mp.
2. Alzheimer.mp
3. exp Dementia/
4. exp Alzheimer Disease/
5. 1 or 2 or 3 or 4
6. exp Cognition Disorders/
7. Cognitive impairment.mp.
8. Cognitive function*.mp.
9. exp mental retardation/
10. 6 or 7 or 8 or 9
11. 5 or 10
Intervention: pain assessment 12. (Assess$ adj5 pain).mp.
13. (Measur$ adj5 pain).mp.
14. (Scale$ adj5 pain).mp.
15. (Rating adj5 pain).mp.
16. exp Pain Measurement/
17. exp Pain/di
18. *Pain Measurement/mt
19. exp *Pain Measurement/
20. (Pain adj3 tool$).mp.
21. 12 or 13 or 14 or 15 or 16 or 17
or 18 or 19 or 20
22. 11 and 21
Limited to study design: reviews 23. meta-analysis.mp.
24. meta-analysis.pt.
25. review.pt.
26. search:.tw.
27. 23 or 24 or 25 or 26
28. 22 and 27
*mp, pt, tw are abbreviations identifying specific fields in the OVID™ MEDLINE
database – e.g. mp = title, abstract, original title, name of substance word,
subject heading word, keyword heading word, protocol supplementary concept,
rare disease supplementary concept, unique identifier. The / after each term is
the OVID™ MEDLINE convention for a MESH term; the ‘exp’ abbreviation refers to
the automatic expansion of a MeSH term to its sub-headings.
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assessed these for eligibility. We identified 23 reviews as
being potentially eligible for inclusion, of which 13 were
excluded as they did not provide data on the psychometric
properties of the tools. The remaining set included 10 re-
cords reporting data from eight reviews (Schofield et al.
[30] review was reported in three separate studies [30-32],
we have combined the results of this) (Figure 2). Table 4
provides details of the eight included reviews and Table 5
details of the 13 excluded reviews.
The findings are structured as follows. First, we briefly
summarise the reviews considered at the time of dataextraction but excluded for lack of data on psychometric
properties of the tools. We then describe the reviews in-
cluded in our analysis – their methods and our quality
assessment. Third, we describe the findings of these
reviews, i.e. the pain assessment tools - characteristics,
psychometric properties, feasibility of use and clinical util-
ity. We conclude with the reviews’ overall assessment of
these tools.
Description of excluded reviews
Thirteen of the 23 reviews were excluded because they
did not provide suitable data for extraction (these data
were absent or not reported in a format suitable for ex-
traction). Several of these were narrative reviews. They
varied in length and details of reporting. Tools were ana-
lysed in the broader context of, for example, pain physi-
ology, pain prevalence, patients’ attitudes and beliefs about
pain. For some the focus were the processes of pain as-
sessment and/or pain management/interventions in the
elderly population, including with (but not always limited
to) persons with dementia (e.g. in [40-42,47]), and/or in
specific types of pain ([44]- orofacial pain). One review
[46] focused on the barriers to successful pain assessment
(of which non-use of assessment tools is one).
Two reviews were updated by, or related to, a later re-
view by the same authors ([40] is an update of [41]– both
excluded; [45] is related to [33] - the latter included in our
study - and aimed at reviewing the methods of the previ-
ous study).
Two reviews [38,39] are review of reviews. They are very
specific in their aims, i.e. to identify pain assessment tools
for cognitively impaired adults recommended for use by
paramedics [38] and district nurses [39]. They identified
two and four reviews respectively, which were amongst
those we also retrieved. Thus, the reasons for exclusion in
their case were: review of reviews (overview, rather than a
systematic review), no data for extraction, and on the
grounds of repetition.
Two other reviews [45,49] did report and discuss psy-
chometric data, but not in a form suitable for this meta
review. Their choice of reporting may suggest authors’
methodological concerns for the comparability and pres-
entation of the data in quantitative form, given the het-
erogeneity of the studies and their methods.
Description of included reviews
Each review included in this meta-review comprised
between eight and 13 tools (Table 6, see also Additional
file 5). The most frequently reviewed tools included: the
Abbey Pain Scale, NOPPAIN, PACSLAC, PADE, CNPI
and PAINAD (Table 7; abbreviations of name of tools
explained in the List of abbreviations used). Reviews
searched the literature across a variety of date ranges,
from 1980 to 2010. The number of individual studies
Is the review a review 
of studies of pain 
assessment or pain 
management?
Is the review a review 
of studies about 
patients with 
dementia or cognitive 
impairment?
Is the review 
a systematic 
review?
Is the 
review in 
English?
Retrieve the paper 
for more information, 
or discuss with other 
reviewer or refer to 
third reviewer
Yes
Yes
Yes
No
No
No
Maybe
Maybe
Maybe
Yes
No
Did both reviewers 
agree on the 
inclusion of the 
review?
Accept
paper   
Refer to third 
reviewer
Yes No
Did both reviewers 
agree on the 
exclusion of the 
review?
Reject
paper   
Yes
Figure 1 Algorithm for inclusion/exclusion of reviews. Screening algorithm (based on inclusion criteria as per Table 1). Each decision point
has the three options for promoting records to the next stage of the winnowing process: ‘yes’ (inclusion), ‘no’ (exclusion), ‘maybe’. Depending
on the stage of the reviewing process (on title and abstract only, or full text), the latter option may require retrieving the full text, discussion
between reviewers, and/or referral to a third reviewer.
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although the number of included studies in some reviews
was ambiguous (Table 6). The reasons for this ambiguity
are twofold. First, the number of studies included in
each review is different for each tool, thus making it diffi-
cult to aggregate in one number (‘number of included
studies’). Second, the studies included in each review were
found each to have reported one or more studies aimed
at evaluating a tool. Thus, a number of included studies
of ‘1’ may actually refer to a larger number of studies
conducted.
The reviews aimed to summarise the available evidence
by means of a comprehensive overview (Additional file 5).
Three reviews [33,35,36] also explicitly aimed at an evalu-
ation of the evidence – i.e. to critically evaluate the exist-
ing tools, or to identify key components and analyse the
reported psychometric properties of tools. Two reviews
[21,33] reported a systematic method for evaluation of
the tools.Not all reviews made explicit their assessment of the
quality of the studies or risk of bias, or assessment of
the scales considered. When this was done, the reviews
highlighted the methodological limitations of both studies
and scales (Additional file 6). For example, in one review
[21] the overall assessment was “generally moderate”, with
11 points being the highest score out of the 20 point
evaluation scale applied, and only four of the 12 tools ex-
amined reaching this score (these were Doloplus-2, ECPA,
PACSLAC, PAINAD). The heterogeneity of study designs
and/or inconsistencies made aggregation of findings in
the reviews difficult and/or methodologically inappro-
priate. For example Zwakhalen et al. [21] stressed the
“Considerable heterogeneity in terms of design (retro-
spective vs. prospective), method (pain in vivo vs. observa-
tional methods), research population (different types
of dementia, different levels of impairment, different
settings) and conceptualisation of pain, making their
results hard to compare”.
Figure 2 Flow chart of retrieved sources and screening process. Overview of the review process and number of retrieved, included and
excluded records.
Table 4 List of included reviews
Review ID Review Notes on inclusion
[25] Corbett A, Husebo B, Malcangio M, Staniland A, Cohen-Mansfield J, Aarsland D, et al.
Assessment and treatment of pain in people with dementia. Nature Reviews Neurology.
2012; 8(5):264–74.
Meets inclusion criteria – data available
on supplementary table
[33] Herr K, Bjoro K, Decker S. Tools for Assessment of Pain in Nonverbal Older Adults with
Dementia: A State-of-the-Science Review. Journal of Pain and Symptom Management.
2006; 31(2):170–92.
Meets inclusion criteria and psychometric
data provided
[34] Smith M. Pain assessment in nonverbal older adults with advanced dementia.
Perspectives in Psychiatric Care. 2005; 41(3):99–113.
Meets inclusion criteria and psychometric
data provided
[35] Qi NS, Brammer JD, Creedy DK. The psychometric properties, feasibility and utility of
behavioural-observation methods in pain assessment of cognitively impaired elderly
people in acute and long-term care: A systematic review. 2012. 2012; 10(17).
Meets inclusion criteria and psychometric
data provided
[36] Juyoung P, Castellanos-Brown K, Belcher J. A Review of Observational Pain Scales in
Nonverbal Elderly With Cognitive Impairments. Research on Social Work Practice.
2010; 20(6):651–64.
Meets inclusion criteria and psychometric
data provided
[30] Schofield P, Clarke A, Faulkner M, Ryan T, Dunham M, Howarth A. Assessment of pain
in adults with cognitive impairment: A review of the tools. International Journal on
Disability and Human Development. 2005; 4(2):59–66.
Include [30-32] as 1 review with 3 publications.
This [30] is the primary reference; meets inclusion
criteria and psychometric data provided
[24] van Herk R, van Dijk M, Baar FP, Tibboel D, de Wit R. Observation Scales for Pain
Assessment in Older Adults with Cognitive Impairments or Communication
Difficulties. Nursing Research. 2007; 56(1):34-43
Meets inclusion criteria and psychometric
data provided
[21] Zwakhalen SMG, Hamers JPH, Abu-Saad HH, Berger MPF. Pain in elderly people with
severe dementia: a systematic review of behavioural pain assessment tools.
BMC Geriatrics. 2006; 6(3).
Meets inclusion criteria and psychometric
data provided
Bibliographic information of the reviews included in this meta-review. For ease of referencing these are also included in the References, with the corresponding
unique identifier.
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Table 5 List of excluded reviews
Review ID Review Reason for exclusion
[37] Thuathail AN, Welford C. Pain assessment tools for older people with
cognitive impairment. Nursing Standard. 2011; 26(6):39–46.
Narrative review. The review covers several tools, with very
little information of each. Comparison is difficult as no
summary table is provided.
[38] Lord B. Paramedic assessment of pain in the cognitively impaired
adult patient. BMC Emergency Medicine. 2009; 9:20.
Narrative review. No data on psychometric properties.
[39] While C, Jocelyn A. Observational pain assessment scales for people
with dementia: a review. British Journal of Community Nursing. 2009;
14(10):438, 9–42.
A review of reviews. No data on psychometric properties of
the tools.
[40] Rutledge DN, Donaldson NE, Pravikoff DS. Update. Pain assessment
and documentation. Special populations of adults. Online Journal of
Clinical Innovations. 2002; 5(2):1–49.
Broad review of pain in a variety of different patient groups -
of which adults with cognitive impairment a subset. No data
on psychometric properties of the tools to extract.
[41] Rutledge DR, Donaldson NE. Pain assessment and documentation. Part
II - special populations of adults. Online Journal of Clinical Innovations.
1998; 1(6):1–29.
No data on psychometric properties of the tools. Review
updated in [40].
[42] Andrade DCd, Faria JWVd, Caramelli P, Alvarenga L, Galhardoni R,
Siqueira SRD, et al. The assessment and management of pain in
the demented and non-demented elderly patient. Arquivos de
Neuro-Psiquiatria. 2011; 69(2B):387–94.
Narrative review, including physiology, assessment and
management of pain. No data on psychometric properties
of the tools.
[43] Scherder E, Oosterman J, Swaab D, Herr K, Ooms M, Ribbe M, et al.
Recent developments in pain in dementia. BMJ. 2005; 330(7489):461–4.
Narrative review, no data on psychometric properties of
tools.
[44] Lobbezoo F, Weijenberg RAF, Scherder EJA. Topical review: orofacial
pain in dementia patients. A diagnostic challenge. Journal of Orofacial
Pain. 2011; 25(1):6–14.
Narrative review. No data on psychometric properties of the
tools. Focus: orofacial pain.
[45] Herr K, Bursch H, Ersek M, Miller LL, Swafford K. Use of pain-behavioral
assessment tools in the nursing home: expert consensus recommendations
for practice. Journal of Gerontological Nursing. 2010; 36(3):18–29;
Expert reviewers were asked to rate each tool and provide a
score; no data on psychometric properties of tools. The way
in which the data are presented makes it unusable for our
purposes.
[46] McAuliffe L, Nay R, O’Donnell M, Fetherstonhaugh D. Pain assessment
in older people with dementia: literature review. Journal of Advanced
Nursing. 2009; 65(1):2–10.
A narrative review with no data on tools. Focus: barriers to
successful pain assessment.
[47] Miller LL, Talerico KA. Pain in older adults. Annual Review of Nursing
Research. 2002; 20:63–88.
Narrative review. No data on psychometric properties of the
tools.
[48] Helfand M, Freeman M. Assessment and management of acute pain in
adult medical inpatients: A systematic review. Pain Medicine. 2009;
10(7):1183–99.
Narrative review. No data on psychometric properties of the
tools.
[49] Stolee P, Hillier LM, Esbaugh J, Bol N, McKellar L, Gauthier N. Instruments
for the assessment of pain in older persons with cognitive impairment.
Journal of the American Geriatrics Society. 2005;53(2):319–26.
30 tools reviewed comparatively in overview tables. Reliability
and validity data reported but in a form unusable for our
purposes.
Bibliographic information of the reviews considered eligible for inclusion in this meta-review, but excluded from the data extraction process. For ease of
referencing these are also included in the References, with the corresponding unique identifier.
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We assessed the quality of the systematic reviews through
the use of the AMSTAR questionnaire (original question-
naire adapted to a binary scoring: 1 if item is present, 0 if
unclear, absent or not applicable) (Table 8). The mean
score was about 4.9, in the range from 1 [34] to 10 [35].
Most (6/8 reviews) presented an a priori design and a
comprehensive literature search (Q1; Q3). However, in gen-
eral, the reporting lacked in detail. For example, as shown
in Table 8, the list of included/excluded studies was
provided in only three reviews [25,35,36]; the explicit
involvement of two or more independent reviewers (Q2)
was reported in only one review [35]; only three reviews
[25,33,35] explained the methods used to combine findings(Q9) and only one review seemed to have assessed the
likelihood of publication bias [35]. This lack of detail in
reporting may be due to restrictions on word limits in
publications; we did not contact the authors to obtain data
when missing.
Reviews’ findings – the pain assessment tools
In total, 28 pain assessment tools were assessed in the
eight reviews; nine tools (Abbey Pain Scale, ADD Protocol,
CNPI, DS-DAT, Doloplus-2, NOPPAIN, PACSLAC, PADE,
PAINAD) were assessed in five or more reviews; one
tool (MOBID) was assessed in three reviews; three tools
(Behavior checklist, Observational Pain Behaviour Tool
and PATCOA) were assessed in two reviews and the
Table 6 Characteristics of included reviews: data sources and number of studies
Review ID Number of
included
studies*
Search dates Databases searched Number
of tools
reviewed
Country of
origin
[25] 18 No data PubMed, MEDLINE, EMBASE 12 UK
[33] No data 1990 - July 2004 MEDLINE, CINAHL, PsycInfo and Health, and Psychosocial Instruments + electronic database of the National Guideline
Clearinghouse + pain and gerontological conferences + personal reference databases of the authors.
10 USA
[34] No data No data MEDLINE, CINAHL, PubMed, EMB Reviews 8 USA
[35] 23 1990-2010 CINAHAL, MEDLINE, Scopus, PsycInfo, ScienceDirect, Wiley-Interscience, Mosby’s Nursing Consult, Web of Science,
ProQuest + reference lists to identify additional studies. Unpublished studies and grey literature not included in review
10 Singapore
and Australia
[36] 21 1990 - 2007 MEDLINE, CINAHL, PsycInfo, Sociological Abstracts, Social Sciences Abstracts, and Ageline 11 USA
[30] 9 1994-2004 AHMED, CINAHL, MEDLINE, EMBASE, Science Citation Index, Psychlit, Ageinfo, Anchor housing, Index for thesis, Steinberg 9 UK
[24] No data 1980-2005 PubMed, MEDLINE, PsycInfo, Cinahl, PiCarta 13 The Netherlands
[21] 29 1988 to January 2005 MEDLINE, PsycInfo, CINAHL + screening citations and references + Unpublished manuscripts were collected by approaching
colleagues working in the field of pain among the elderly + abstract books of the 7th, 8th, 9th and 10th International
Association for the Study of Pain World Congresses screened for relevant publications
12 Lebanon and
Netherlands
Overview of the scope of the retrieval strategies (sources and periods) for studies of pain assessment tools, used in the reviews included in our meta-review. Information was missing for four of the reviews (no data available
for extraction). * The number of included studies is possibly approximate. The reasons are twofold: 1) the number of included studies in each review is different for each tool and hard to aggregate in one number; 2) the
studies included in each review may have reported one or more studies aimed at evaluating a tool – i.e. a number of included studies of ‘1’ may actually refer to a larger number of studies conducted.
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Table 7 Summary of how often the tools appear in the
reviews (in alphabetical order)
Name of tool Number of reviews
they appear in
Review IDs
Abbey pain scale 7 [21,24,25,30,33,35,36]
ADD Protocol 5 [24,30,33,34,36]
Behavior checklist 2 [24,36]
CNPI 8 [21,24,25,30,33-36]
Comfort checklist 1 [34]
CPAT 1 [35]
Doloplus-2 6 [21,24,25,30,33,35]
DS-DAT 6 [24,25,30,33,34,36]
ECPA 1 [21]
ECS 1 [21]
EPCA-2 1 [25]
FACS 1 [24]
FLACC 1 [33]
Mahoney pain scale 1 [35]
MOBID 3 [25,35,36]
NOPPAIN 7 [21,24,25,30,33,35,36]
Observational pain
behaviour tool
2 [21,34]
PACSLAC 7 [21,24,25,30,33,35,36]
PADE 7 [21,24,25,30,33,34,36]
Pain assessment scale
for use with cognitively
impaired adults
1 [21]
PAINAD 8 [21,24,25,30,33-36]
PAINE 1 [25]
PATCOA 2 [24,36]
PBM 1 [24]
PPI 1 [25]
PPQ 1 [34]
RaPID 1 [21]
REPOS 1 [35]
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Table 7; a summary of each provided in Additional file 7).
It should be noted that there seem to be different ver-
sions of PACSLAC: a preliminary 60 items one, then modi-
fied to 36 items. There seems to be ambiguity about which
version of the tool the data are reported about (a Dutch
version – PACSLAC-D was also mentioned [25]). Similar
ambiguity was found in relation to PADE, being unclear
which version – or which of its subscales - was studied for
psychometric properties. Similarly, the MOBID tool has
been studied in two different versions. It is also unclear
how much the Abbey Pain Scale had been refined acrossthe studies carried out to evaluate it (including a Japanese
version).
Description of the tools
The reporting of the tools’ content and intended use was
done differently by different reviews, making it difficult to
provide a comprehensive comparative descriptive summary
of all the 28 tools. Six of the eight reviews [21,24,25,30,34,36]
provided summary tables giving an overview description
of tools’ design but these summaries focus on a varied
range of aspects including: target population [24], number
of items [21,24,25], type of behaviours identified [30,33,34],
number of dimensions/behaviours [21], presence of the
American Geriatric Society (AGS) categories [24,33,36]
and scoring range [21,24].
From the eight reviews, it appears that most tools (24
out of 28) are observational (Additional file 7), requiring
observations by healthcare professionals. However, re-
viewers’ classification of these observational tools varied:
FLACC was described as a ‘behavioural scale’ rather than
observational [33]; Abbey Pain Scale, PADE and PAINE
were classified by one review [25] as ‘caregiver or inform-
ant rating scales’; the same review [25] classified the ADD
tool as ‘interactive’– i.e. an “interactive method” including
“a physical and affective needs assessment, a review of the
patient’s history, and the administration of analgesic medi-
cation” [25]. In a number of reviews no specific classifica-
tion is made. Among the remaining four tools of the 28,
one (PPI) relied on patient self–reporting and one (PPQ)
was described as relying on caregivers reporting and com-
pared pain experienced currently with pain experienced
the previous week.
Twenty-five of the 28 tools appear to include an as-
sessment of pain intensity. Three tools (ADD Protocol,
Behavior checklist, Observational Pain Behaviour Tool)
aimed at determining presence or absence of pain, with
no scoring or rating of pain intensity. In the case of two
tools (Doloplus-2 and REPOS) binary scores are summed
up and the total score interpreted as presence/absence of
pain.
Methods of scoring and rating of pain varied, from
scores made of counting checkmarks – i.e. yes/no binary
responses (item present or absent), to a variety of rating
systems; total scores ranges varied from 0–6 to 0–60 – i.e.
0–6 (CNPI), 0–9 (PATCOA), 0–10 (FLACC, MOBID,
PAINAD), 0–14 (ECS), 0–25 (Observational Pain Be-
haviour Tool), 0–27 (DS-DAT), 0–30 (Doloplus), 0–44
(ECPA), 0–54 (RAPID), and 0–60 (PACSLAC). Likert
scales, binary scores, multiple choice and Visual Analogue
Scale (VAS) systems were mentioned in the reviews; in
three cases (PADE, Pain assessment scale for use with
cognitively impaired adults, PPQ) different rating sys-
tems are used in the same tool (Likert scales/VAS;
Likert scales/binary scores).
Table 8 Summary of quality of systematic reviews
Review
ID
Q1 -
Was an
‘a priori’
design
provided?
Q2 -
Was there
duplicate
study
selection
and data
extraction?
Q3 -
Was a
comprehensive
literature search
performed?
Q4 -
Was the
status of
publication
(i.e. grey
literature)
used as an
inclusion
criterion?
Q5 -
Was a list
of studies
(included and
excluded)
provided?
Q6 -
Were the
characteristics
of the included
studies provided?
Q7 -
Was the
scientific
quality of the
included
studies
assessed and
documented?
Q8 -
Was the
scientific
quality of
the included
studies used
appropriately
in formulating
conclusions?
Q9 -
Were the
methods
used to
combine
the findings
of studies
appropriate?
Q10 -
Was the
likelihood
of publication
bias assessed?
Q11 -
Was the
conflict
of interest
stated?
Total
score
[25] 1 0 1 0 1 1 0 1 1 0 1 7
[33] 1 0 1 1 0 1 1 0 1 0 0 6
[34] 0 0 0 0 0 1 0 0 0 0 0 1
[35] 1 1 1 0 1 1 1 1 1 1 1 10
[36] 1 0 1 0 1 1 1 0 0 1 0 5
[30] 1 0 1 0 0 0 0 1 0 0 0 3
[24] 1 0 1 0 0 0 0 0 0 0 0 2
[21] 1 0 0 1 0 0 0 1 0 0 1 4
Mean 4.875
Assessment of the quality of the included reviews by application of the AMSTAR Questionnaire [28], adapted to a binary scoring – items scored 1 if present, 0 if unclear, absent or not applicable. The questionnaire is
composed of 11 closed questions, with possible answers: Yes, No, Can’t Answer and Not Applicable. The quality assessment we carried out relied on the information reported in the review - we did not contact the
authors of the reviews to gather information which was missing or ambiguous in their publication. As a consequence, it may be possible that the authors had performed, for example, a comprehensive literature
search for their review, but they did not report this in sufficient detail in their publication. This also caused uncertainty and ambiguity between the No and Can’t Answer options, with blurred boundaries between the
two. In addition, the AMSTAR questionnaire presents some double-barrelled questions (Q2, Q5, Q7) and we scored the item as present (a score of 1) only when both items in the question were answered positively. So,
for example, only when both the lists of included and excluded studies were provided (Q5) a score of 1 would be awarded to the review.
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be designed explicitly for pain assessment at both rest
and during movement – though data about this aspect
of the tool’s design may be missing for the other tools.
For one tool (Doloplus-2) the score was reported to re-
flect the progression of the pain experienced, rather than
the patient’s pain experienced at a specific moment in
time.
Two tools (REPOS and ADD Protocol) combine assess-
ment with guideline for intervention (this is discussed fur-
ther in the next section).
Three reviews [24,33,36] explicitly analyse the tools in
terms of whether their design apply the AGS [13] guidelines
and categories of potential pain indicators in older persons,
namely facial expressions, verbalizations/vocalizations, body
movements, changes in interpersonal interactions, changes
in activity patterns or routines, and mental status. These
reviews cover 15 tools (Abbey Pain Scale, ADD, Behavior
checklist, CNPI, DS-DAT, Doloplus-2, FACS, FLACC,
MOBID, NOPPAIN, PACSLAC, PADE, PAINAD, PATCOA,
and PBM).
Settings where the tools were studied
The tools were studied in a variety of settings and with var-
ied patient populations. The terminology used to describe
settings varied, and those which appeared to be in non-
acute settings included: long-term-care, nursing homes,
dementia care units, psychogeriatric units, rehabilitation
facilities, aged care facilities, residential care facilities, long-
term care facilities, palliative care but also, geriatric clinics,
care homes, residential and skilled care facilities, long-
term-care dementia special care units, and a residential de-
mentia care ward (Additional file 8).
The terminology to refer to hospital settings also varied,
with reference either to patients and/or type of services:
e.g. hospital patients in a long-term stay department,
psychiatric hospital setting, hospital medical care unit,
dementia special care units in hospital, hospital pa-
tients and older hospital patients.
Tools psychometric data
Reliability
The reliability of pain assessment scores was measured
using inter-rater reliability (agreement between raters),
test-retest (extent to which a tool achieves the same result
on two or more occasions when the condition is stable) or
intra-rater reliability (agreement of the same rater at dif-
ferent time points) and internal consistency (Additional
file 9). There were no reliability data available for four of
the tools (ECS, Pain assessment scale for use with cogni-
tively impaired adults, Observational Pain Behaviour Tool
and Behavior Checklist). Overall, reliability measures were
carried out on small samples of patients and raters, so
data for all of the tools are limited.Inter-rater reliability This was calculated in different
ways for each of the tools. Methods included percentage
agreement, kappa coefficients, correlation coefficients,
and intra-class correlation coefficients. The variation in
calculation of reliability of the different tools makes dir-
ect comparisons difficult. Percentage agreement is the
least robust measurement of reliability, and was used to
calculate agreement for the FACS (43-93%), CNPI (93%),
DS-DAT (84-94%), PACSLAC (94%), PATCOA (56.5-100%),
NOPAIN (82-100%), and ADD protocol (86-100%). The
kappa coefficient measures agreement between two
observers and takes into account the agreement expected
by chance. It is therefore a more robust measure than
percentage agreement. With Kappa coefficients a value
of 0.6 or above indicates moderate agreement. Kappa
coefficients were provided for the FLACC (0.404),
Mahoney Pain Scale (0.55-0.77), CNPI (0.625-0.819),
MOBID (0.05-0.90), MOBID-2 (0.44-0.90), NOPAIN
(0.70-0.87). Correlation coefficients were used to assess
agreement for the following tools; FACS (0.82-0.92),
PAINE (0.711-0.999), RaPID (0.97), DS-DAT (0.61-0.98),
PAINAD (0.72-0.97). Measures of inter-rater reliability
using intra-class correlations were as follows: CPAT
(0.71), PBM (0.10-0.87), DS-DAT (0.74), Doloplus-2
(0.77-0.90 total scale, 0.60-0.96 subscales), PACSLAC
(0.77-0.96), PADE (range from 0.54-0.96), ECPA (0.80),
EPCA-2 (0.852-0.897), MOBID (0.70-0.96), and Abbey
pain scale (0.44-0.845). There were no inter-rater re-
liability data provided for the PPQ.
Overall, the majority of the tools assessed had moder-
ate to good inter-rater reliability. However, there were
limitations in terms of the sample sizes used to evaluate
their reliability.
Test-retest and intra-rater reliability Intra-rater reli-
ability was not assessed for the FLACC, Mahoney Pain
Scale, PBM, PPI, PAINAD, PATCOA, ECPA, EPCA-2
and the ADD protocol. Evaluations of intra-rater reliabil-
ity included percentage agreement, correlation, kappa,
Nygard test-retest and intra-class correlations. In terms of
intra-rater reliability, the variation in calculations makes
direct comparison across the tools difficult and the
use of small sample sizes indicates that all of the results
should be treated with caution. Percentage agreement
for intra-rater reliability was provided for the FACS
(79-93%), correlations for the FACS (0.88-0.97), PAINE
(0.711-0.999) and RaPID (>0.75), DS-DAT (0.6), kappa co-
efficients for MOBID-2 (0.41-0.83 (pain behaviour), 0.48-
0.93 (visual pain recordings)), Nygard test-retest for the
CNPI (0.23-0.66) and intra-class correlations for the
CPAT (0.67), REPOS (0.90-0.96), PACSLAC (0.72-0.96),
PADE (0.70-0.98), MOBID (0.60-0.94), and Abbey Pain
Scale (0.657). As with inter-rater reliability, the values
indicate moderate to good temporal stability.
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available for the Mahoney Pain Scale (total scale a = 0.76,
subscales range 0.68-0.75), PAINE (0.75-0.78), RaPID
(0.79), REPOS (0.49), CNPI (0.54-0.64), Doloplus-2 (0.668-
0.82), PACSLAC (0.74-0.92), PADE (0.24-0.88), PAINAD
(0.5-0.74, PATCOA (0.44), ECPA (0.70), EPCA-2 (0.73-
0.79), MOBID (0.82-0.91), MOBID-2 (0.82-0.84), and
Abbey Pain Scale (0.645-0.81). There was considerable
variation in the internal consistency of scales, with the
MOBID and MOBID-2 indicating the highest internal
consistency and the PADE, PATCOA and PAINAD having
some of the lowest ratings.
Validity
The validity of the pain tools was primarily explored using
concurrent and/or criterion validity (correlation of the pain
scale with other pain scores or a benchmark criterion)
and/or discriminant and/or predictive validity (e.g. ability
to discriminate, or predict between pain on movement and
at rest) (Additional file 9). Some reviews (e.g. [21,33]) also
provided brief insight into the conceptual foundation
of the measures and ways content validity was explored.
As with measures of reliability, there was considerable
variation in how the validity of tools was assessed. Three
tools had no validity assessment (the Comfort check-
list, the Pain assessment scale for use with cognitively
impaired adults and the Observational Pain Behaviour
Tool). The Non-Communicative Patient’s Pain Assessment
Instrument (NOPAIN) tool also had little overall formal
validity assessment.
Content validity
In general, only limited insight was provided into the con-
ceptual foundation of the tools (as opposed to the tool’s
purpose) (Additional file 10). For the vast majority of tools,
their derivation, and thus the implied conceptual basis, lay
in literature reviews and/or clinical and/or research experts
in pain and older patients with dementia. For other tools,
for example, the Abbey Pain Scale, its basis was unclear or,
as with the Behaviour Checklist, no information was pro-
vided. Two of the measures were adapted from measures
originally developed for a different patient group, in par-
ticular, young children (Doloplus-2; ECPA). In contrast,
the purpose of all the measures was commonly outlined. It
is notable that some were developed for particular users
(CPAT, for certified nursing assistant care providers; NOP-
PAIN, for nursing assistants), another for research pur-
poses (DS-DAT) and two as decision support tools (the
ADD Protocol and the REPOS).
Concurrent and criterion validity
Concurrent and criterion validity were measured by either
comparing the scores of one tool to another, or comparing
one tool’s scores with nurse/doctor ratings of pain, orthrough comparison with self-report (using VAS scales)
(Additional file 11). The following is a summary of the
comparisons:
 CPAT was compared to DS-DAT (rs = 22, p = 0.076,
rs = 0.25, p = 0.048)
 PAINAD compared to the DS-DAT (0.56-0.76)
 DS-DAT compared to the Pittsburgh Agitation
Scale (0.51) and the Cohen-Mansfield Assessment
Inventory (0.25)
 Doloplus 2 compared with the PAINAD (0.34) and
PACSLAC (0.29-0.38)
 REPOS compared to PAINAD (0.61-0.75)
 FACS was compared to PBM (0.02-0.41)
 PAINE compared with PADE (r = 0.65)
 PADE compared to CMAI (0.30 – 0.42)
 PPI compared with the Memorial pain Subscale
(0.67), Verbal scale (0.54), RAND Health Survey
and Dartmouth COOP chart (0.72)
 RaPID compared to McGill pain scale (0.8-0.86).
Comparisons to proxy pain reports (doctor or nurse) was
as follows; Mahoney pain scale (k = 0.86), PAINAD (0.84),
the PBM (0.62-0.73), MOBID (0.41-0.64), Abbey Pain Scale
(0.586), PACSLAC (0.35-0.54), and REPOS (−0.12-0.39).
Comparison to self-report (using a VAS) included RaPID
(0.8-0.86), EPCA-2 (0.846), DS-DAT (0.56-0.81), PAINAD
(0.75 pain VAS and 0.76 discomfort VAS), ECPA (0.67),
Doloplus 2 (0.31-0.65), PPI (0.55), CNPI (0.30-0.50),
PATCOA (0.41), and PBM (r = 0.11-0.30).
Overall, the tools which had the highest correlations with
each other were the RaPID when compared to the McGill
pain scale, the REPOS compared to PAINAD and the PPI
compared to the Memorial pain Subscale. The Mahoney
pain scale and the PAINAD had the highest correlation
with nurse/doctor ratings of pain, and the RaPID with self-
reports of pain/discomfort. There was no one scale that
appeared to be superior to the others (nor applicable as a
gold standard), and no consistency in comparisons across
the scales.
Discriminant validity
Discriminant validity was measured by comparing scores
before or after a painful event. Several of the reviews re-
ported that tools had discriminant or predictive validity
without providing data – this included the reviews of the
FACS and PBM. Other scales with a significant difference
in scores pre and post interventions/events included the
CPAT, CNPI, DS-DAT, PACSLAC, MOBID, Abbey Pain
Scale, ADD protocol, and the Behaviour checklist.
Construct validity
Construct validity was measured by comparing scores to
medication use or prescription of medications. The PPQ
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0.55), and patients assessed with the PADE on psycho-
active medications had significantly higher scores on the
physical and verbal agitation subscales. With the PAINAD
there was a significant fall in score after the administra-
tion of pain medication, and the EPCA-2 was correlated
with the prescription of opioids (0.782) and non-opioids
(0.730).
Feasibility and clinical utility
The feasibility of a tool is “its applicability in daily prac-
tice”, including aspects such as ease of use and time to ad-
minister it, while clinical utility is “the usefulness of the
measure for decision making”, i.e. to inform further ac-
tion, such as the administration of analgesics [24]. Data on
feasibility and clinical utility of tools were very limited
(Additional files 12 and 13). Often data were not available
in the reviews, or when data were available, it often
pertained to a lack of data in the original studies (e.g. re-
viewers stating the item was not reported and could there-
fore not be assessed). More specifically: feasibility data
were completely absent for six tools (Comfort Checklist,
FLACC, PAINE, PATCOA, PPI, and PPQ); clinical utility
data were completely or substantially absent for seven
tools (ECS, FACS, Mahoney Pain Scale, PAINE, PBM,
PPQ, and RaPID). For four tools reviewers explicitly noted
that claims of feasibility (e.g. time required to admin-
ister the tool) were made from the authors of the study
without supporting evidence (Abbey Pain Scale, Doloplus-
2, PACSLAC, and PADE). There were also two in-
stances (PACSLAC and MOBID) of conflicting data
on clinical utility and feasibility from the different re-
views, possibly due to an ambiguous reference to different
versions of the same tool.
Specific evaluation for feasibility appears to have been
carried out only for three tools - CPAT, Mahoney Pain
Scale, and Pain Assessment Scale for Use with Cogni-
tively Impaired Adults; in the first two of these cases the
evaluation was done by use of questionnaires. It also ap-
peared that users of the Abbey Pain Scale were asked for
feedback in the context of the psychometric testing of
the tool. In was unclear whether the ADD Protocol was
also assessed for feasibility.
Specific evaluation of clinical utility appeared to have
been undertaken for the Pain Assessment Scale for Use
with Cognitively Impaired Adults, and possibly for the
ADD Protocol and PAINAD.
It must be stressed that when reviews assessed or
mentioned the feasibility and/or clinical utility of the
tools, the two aspects were often confounded (reviewers,
authors or users typically drawing conclusions from ease
of use or brevity of a scale to its usefulness).
Specific dimensions of feasibility assessed were: time to
complete the assessment (e.g. to complete a checklist),availability of instructions on how to use the tool and/or
availability of guidelines on how to score pain, and train-
ing needs (Additional file 12).
Six tools were reported to be overall ‘easy to use’
(Abbey Pain Scale, Behavior checklist, CNPI, CPAT,
Mahoney Pain Scale, and NOPPAIN), two were consid-
ered manageable/acceptable (ECPA, and RaPID), four
were judged to be complex (ADD Protocol, DS-DAT, Pain
assessment scale for use with cognitively impaired adults,
and PADE). Conflicting views on the ease of use or com-
plexity of the tools were apparent for five tools (Doloplus-
2, MOBID, PACSLAC, PAINAD, and PBM).
Instructions for use and/or guidelines on scoring were
reported to be available for 13 tools (Abbey Pain Scale,
CNPI, CPAT, Doloplus-2, DS-DAT, ECS, FACS, Mahoney
Pain Scale, MOBID, NOPPAIN, PACSLAC, PAINAD,
REPOS) with varied assessments in terms of clarity or
complexity of the instructions.
Training in the use of the tool was judged as necessary
for 10 tools (EPCA-2, Mahoney Pain Scale, NOPPAIN,
PADE, PACSLAC, PAINAD, ADD Protocol, CPAT, DS-
DAT, and MOBID), four of which seemed to require sig-
nificant training (ADD Protocol, CPAT, DS-DAT, and
MOBID). For six tools it was stated that authors of studies/
tools did not report on the level and length of training re-
quired (Abbey Pain Scale, CNPI, Doloplus-2, PAINAD,
PACSLAC, REPOS). For the majority of the tools however,
data about training were not available (Behavior checklist,
Comfort Checklist , ECPA, ECS, FACS, FLACC, Observa-
tional Pain Behaviour Tool, Pain assessment scale for use
with cognitively impaired adults, PAINE, PATCOA, PBM,
PPI, PPQ, and RaPID).
Specific dimensions of clinical utility were less straight-
forward. The availability of cut-off scores and of interpret-
ation of scores for decision making appeared to be the two
dimensions supporting evidence of clinical utility. The
presence of cut-off scores contributes to achieving clinical
utility, for example to help discriminate between presence
and absence of pain, or to couple the scale with a treat-
ment algorithm. Otherwise, general statements were avail-
able related to evidence of use in clinical settings and
evidence of clinical utility, the latter being dependent on
the first (Additional file 13).
Cut-off scores appeared to be available only for REPOS
and Doloplus-2, though in the latter case they still need to
be validated. The availability of guidance on how to inter-
pret the scores and for further action following assess-
ment was variedly reported. Data on this were missing for
18 tools (ADD Protocol, Behavior checklist, Comfort
Checklist, DS-DAT, ECS, EPCA-2, FACS, FLACC, Mahoney
Pain Scale, MOBID, Pain Assessment Scale for Use with
Cognitively Impaired Adults, PAINE, PATCOA, PBM,
PPI, PPQ, RaPID, and REPOS). For four tools it appeared
that interpretations of the scores were available (Abbey
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these they were deemed unclear (CNPI, and CPAT). For five
tools, it appeared interpretations of the scores were not avail-
able (ECPA, NOPPAIN, Observational Pain Behaviour Tool,
PACSLAC, and PADE) and further four were reported as
lacking guidance for further action following assessment
(CNPI, CPAT, Doloplus-2, and NOPPAIN). It was unclear
whether PAINAD does provide interpretation of scores.
Suggestive evidence of use in clinical settings was re-
ported for two tools: Abbey Pain has been incorporated
into the Australian pain guidelines; and the ADD Protocol
was introduced in 57 long term care facilities together
with an education strategy for 12 months and the evalu-
ation was done in a study with 32 nurses in 25 facilities. It
is otherwise unclear whether any of the other tools were
actually used in practice beyond a period of research or
testing of the tool. In one example (NOPPAIN), the test-
ing of the tool was done by use of video recording of an
actress portraying a bed-bound patient, and it remains un-
clear whether further testing was done in clinical setting
or with patients at bedside.
With the exception of the ADD Protocol and REPOS,
there was no mention of how the tools would inform inter-
vention (e.g. choice of treatment). We found an overall
lack of clarity in the descriptions of the ADD Protocol, but
it seems that one of its strengths is that it links observation
of behaviour with interventions. Similarly, one review sug-
gested that the clinical utility of REPOS potentially resides
in its combination with a decision tree to assist in deter-
mining interventions after pain assessment [35].
Overall assessment of the tools
There seemed to be a general consensus among the re-
viewers that the current evidence on validation and clin-
ical utility of the tools is insufficient (Additional file 14).
The overall conclusion was that there is a need for fur-
ther psychometric testing of each tool. Two reviews rec-
ommended that the focus should be on studying existing
scales rather than creating new ones [21,30], although
one review also suggested that there may be a need to
revisit the tools’ conceptual foundations [33].
Recommendations for further research and testing of the
tools included the involvement of culturally diverse popu-
lations [21,33,36] and the provision of scoring methods
and guidelines for interpretation in the evaluation of the
scale [36]. Finally, a need for research emerged to link as-
sessment with treatment algorithms [24].
Some of the reviews also concluded with recommenda-
tions for practice, for example: the use of at least two dif-
ferent pain assessment approaches at the same time in
clinical practice and two different tools in research [25];
the importance of a comprehensive approach to pain as-
sessment beyond the use of tools [33]; the need to involve
social workers in regular holistic multidisciplinary painassessment (in nursing homes), with training in the use of
the scales [36].
Among the tools selected by the reviews as possible best
candidates, albeit on limited evidence, were the DS-DAT,
Doloplus 2, Mahoney Pain Scale, PACSLAC, PAINAD,
Abbey Pain Scale, and ECPA. The ADD protocol was
mentioned as an example of a more comprehensive ap-
proach for the identification of pain, beyond the use of an
assessment tool as “a standardized tool is only one step in
a complex diagnostic process” [33]. There was also agree-
ment on recommending that patients with dementia can
often reliably verbalise their pain, suggesting therefore
that the use of observational scales should be limited
to patients who demonstrably cannot reliably verbalise
their pain.
Discussion
The objective of our meta-review was to identify which
tools are available to assess pain in adults with dementia,
in which settings and patient populations they have been
used, and evaluate their reliability, validity, feasibility and
clinical utility. We found a relatively large number of re-
views on this topic and a considerable number of pain
assessment tools available for the cognitively impaired
population. Of the reviews we evaluated, only one [35]
met all of the quality criteria outlined in the AMSTAR
checklist, and would be considered a high quality review.
The review by Herr et al. [33] has an associated website
where 17 tools (specifically for use in nursing homes) are
listed and commented on in detail [50].
The systematic reviews commonly situated their choice
of interventions to review in the context of the challenges
associated with assessing pain in patients who were cogni-
tively impaired. Whilst there was recognition that the gold
standard for pain assessment was the patient’s own assess-
ment, this was unlikely to be possible with this patient
population if the person was severely cognitively impaired,
thus leading to the use of observational scales. The tools
included in these reviews were therefore for the greater
part observational, but showed a broad variation of mea-
sures and methods of assessing pain in adults with demen-
tia. The foundation and focus of an observational scale is
how the pain is manifested or made known such as on the
basis on the American Geriatric Society (AGS) Pain indi-
cators [13]. An additional conceptual foundation resided
on a differentiation of aspects of pain – such as “the
sensory-discriminative and motivational-affective aspects”
[43]. Very few tools appeared to have any strong theoret-
ical underpinning to the development.
Overall there was no one tool that appeared to be
more reliable and valid than the others. There was con-
siderable variation in how reliability and validity of the
tools were assessed. The majority of reliability and valid-
ity assessments were carried out on small samples in
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tools across settings is yet to be evaluated. Similar con-
clusions can be drawn in relation to the feasibility and
clinical utility of the tools. These findings have implica-
tions for research, which we briefly discuss over four
points.
First, given the large number of existing tools identified
within our meta-review, it seems inappropriate to develop
further tools if on the basis of the same conceptual foun-
dations. Instead, researchers need to either envision new
assessment instruments on the basis of different concep-
tual foundations, or concentrate on extending the psycho-
metric evidence base for the existing tools. There is a need
to evaluate the tools on a wider scale, across a variety of
patients and clinical settings, using rigorous methods and
larger sample sizes. The studies need to ensure that the
definitions of cognitive impairment and type of pain that
is being assessed are clearly defined, to enable compari-
sons across populations. While rigorous research is
needed, it must be noted that the accuracy of tools is
difficult to assess when an objective biological marker
or other gold standard criterion is lacking - such as is the
case for pain intensity [35,48,49].
Second, research should be conducted in clinical prac-
tice to assess the feasibility and clinical utility of the
tools, and thus their potential for use in everyday clinical
practice. Tools may be more useful in detecting relative
changes in individual patients than differences between
patients [41]. Tools that showed high reliability in re-
search may not display to be highly reliable in routine
clinical practice if not administered as intended [51]. Pain
assessment tools designed for research purposes, in order
to aggregate and compare data across patients, do not ne-
cessarily transfer easily and effectively to clinical settings
for everyday use. In general it has been suggested that
measurement tools developed for the purpose of evalu-
ation of policy making [52,53] or routine general screening
[51] might have ‘no meaning’ at the frontline.
Third, research on the clinical utility of the tools should
include evaluation of their impact in terms of choice of
treatment and patient outcomes. This question was con-
sidered in one of the excluded reviews [48]: the reviewers
found no evaluations of the effect of protocols such as al-
gorithms or pathways for assessing pain in inpatients (in-
cluding those with dementia) and they reported “a study
in cancer patients [that] found opioid-related over sed-
ation and other adverse effects increased substantially
after implementation of pain assessment on a numerical
scale routinely with other vital signs” ([48], p11, citing
[54]). Herr et al. [33] reported that “the use of the ADD
Protocol was associated with a significant increase in the
use of pharmacologic […] and non-pharmacologic com-
fort interventions” (p179). Alternatively, the use of the
wrong pain assessment tool might reduce the likelihoodthat pain treatment will be initiated or contribute to acute
exacerbations of pain (as could be inferred by data from
[34]), or may be found to have no effect on the quality of
pain management [55].
Finally, an instrument must be relevant to “the condi-
tion, setting and participants in the health interaction, in
particular the patient and clinical users” [56]. This in-
cludes the notion of user-centredness, defined as “the ex-
tent to which an instrument faithfully captures both the
content of the health care user’s views and the form or
ways in which their views are expressed” [57]. As a num-
ber of the systematic reviews and other literature makes
clear, pain is a subjective experience; thus the associated
measurement gold standard is the patient’s own assess-
ment [24]. However, where the patient is severely cogni-
tively impaired, alternative ways to assess the patient’s
level of pain must be found. Resort is made to behav-
ioural indicators and groups of cues [58]. Ideally, these
aspects would be used to assess expressed pain when the
patient is at rest and when moving. Against this context,
user-centredness, in terms of the actual patient’s self-
assessment of pain, is unachievable. The next best option,
from a user-centred perspective, becomes the assessment
of a person who is most familiar with the patient in their
everyday life in a hospital or other care setting – what
Herk et al. [24] call a “silver standard”. It is critical, how-
ever, that the assessor has a high familiarity with the pa-
tient. It can plausibly be argued that the more this is
achieved, the greater the likelihood of a closer fit of the
proxy’s view with the patient’s own experience. At the
same time, over-familiarity may lead to an attenuation of
the observer’s focus on potential pain clues. However, as
Smith [34] commented, one is rarely in ‘an ideal situation’
where the direct care providers know, and are thus highly
familiar, with the care recipient’s personal habits and his-
tory. Thus, rather than seeking to review the degree of the
user-centredness of tools in this area, it is important to
evaluate the guidance on a tool’s use (that is, who should
administer the intervention and in what range of situa-
tions) and then explore whether or not it is actually used
in the indicated way in everyday clinical practice. Explor-
ation and findings on clinical utility and feasibility of use
provide suggestive evidence of potential for use in every-
day practice. Such evidence is a necessary but not suffi-
cient condition for a tool’s actual use. It is notable that
little or no insight is provided into the guidance over who
should administer the tools in any of the systematic re-
views. To gain insight into this aspect of use and possible
additional evidence on a tool’s actual use in practice,
one would need to examine the original instrument
designers’ papers and validation studies, rather than rely
on a systematic reviewer’s observations or summaries.
Notwithstanding, it can be recommended that these
two aspects of tool use (guidance and actual use) are
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group, development of evidence on the actual use of
the tools in clinical practice.
Overall completeness and applicability of evidence
We analysed 23 reviews for data extraction and included
data from eight of these. Whilst we could have been
more strict in our interpretation of the criteria for a sys-
tematic review and exclude a greater number of poten-
tially eligible records before reaching the stage of data
extraction, this would not have necessarily restricted the
analysis to reviews with higher AMSTAR scores. It would
have given us a smaller number of records for data extrac-
tion, and while this would have saved us time in the data
extraction process, we do not believe that it would have
changed the final outcome and the findings. It would also
have reduced the number and range of tools assessed.
We analysed 28 tools included in eight reviews. However
other tools are also available and were included in some of
the reviews we excluded because they did not provide psy-
chometric data for extraction. The review by Stolee et al.
[49], for example, covers 30 tools, including The Proxy
Pain Questionnaire, The Pain Behavior Measure, the 21-
Box Scale, and the Pain Thermometer, among others.
Furthermore, this meta-review does not cover a new
tool recently developed in France by the Doloplus Col-
lective team – ALGO Plus [59]. To our knowledge, the
tool has not been included yet (at the time of writing)
into a systematic review.
Potential biases in the overview process
We checked further available data when readily avail-
able, such as in supplementary tables online [25] but we
did not communicate with the authors to obtain missing
data. This may have introduced publication bias.
In our assessment of the reliability and validity of the tools,
we did not attempt a meta-analysis; we are aware that studies
had been counted in various reviews and their results could
have been counted more than once. However, we do not
believe this to be an issue for our narrative synthesis.
Our search did not specifically target reviews reporting
on the feasibility or clinical utility of the tools – thus our
evidence may be more limited on these aspects than it
might have been otherwise.
We attempted to minimise bias in the review process by
involving a review team with diverse expertise; by having
each review assessed independently by at least two mem-
bers of the team, and the whole team of reviewers involved
at every stage of the process; by not excluding reviews on
the basis of our assessment of their quality.
Conclusions
The assessment of pain in patients with dementia is
challenging for clinicians, due to some patients’ inabilityto verbalise the nature of their pain. This review highlights
the current state of the evidence base in relation to pain
assessment tools, and provides insights into current gaps
in our understanding. We identified a total of 28 tools that
could possibly be used in clinical practice to help with this
process; however we cannot at present recommend any
particular tool for use in any clinical setting, due to the
lack of comprehensive evidence on the reliability, validity,
feasibility or clinical utility of any one particular tool. Fur-
ther research should be conducted on the psychometric
properties of tools and in clinical practice to assess feasi-
bility, clinical utility and guidance on use of the tools.
These are necessary albeit not sufficient pre-requisites for
actual use in routine clinical practice. Throughout, the
aim remains the same: to gain as good an assessment as
possible of the patient’s pain with a view to effective pain
management.
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